Health Policy and Cardiovascular Medicine

نویسندگان

  • Terry Shih
  • Lena M. Chen
  • Brahmajee K. Nallamothu
چکیده

2151 Episode-based, “bundled” payments have come to the forefront of the national discussion on combating rising healthcare costs. In the currently dominant fee-for-service model for reimbursement, hospitals, physicians, and postacute care providers file distinct claims and are paid separately for provided services even when they are related to a single episode of care. However, this approach to payment encourages fragmented care, with little incentive for resource stewardship, coordination, or communication across multiple providers. In contrast, bundled payments seek to align the interests of providers by providing a fixed payment for all services given during a single episode of care. This payment is distributed among all providers in a healthcare system involved with that patient, including hospitals and other facilities. Although not a new policy initiative, bundled payments have resurfaced in the current era of healthcare reform, with its advocates arguing that it can curtail healthcare costs while simultaneously improving quality. Cardiovascular care is the arena in which implementation of bundled payments is arguably most visible and may be most impactful. Many previous demonstrations of bundled payments have concentrated on cardiovascular conditions, and it is likely that future efforts will continue to do so, with good reason. First, cardiovascular diseases are common, costly, and deadly and therefore are important in national discussions for healthcare reform. Second, care for cardiovascular disease involves multiple providers from different disciplines (primary care, cardiology, cardiac surgery, anesthesiology, radiology). Lastly, cardiovascular patients receive care in multiple healthcare settings (hospital, outpatient primary care and subspecialty clinics, skilled nursing facility, etc). Given all these factors, bundled payments have the potential to substantially improve care coordination and to generate savings for cardiovascular care. In the present article, we further explore bundled payment initiatives and their potential advantages and disadvantages, focusing our review on previous and current bundled payment programs for cardiovascular conditions. We end by discussing what implications these programs might have as healthcare reforms takes further shape in the coming years.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Estimation of the Economic Burden of Cardiovascular Diseases in Selected Hospitals of Yazd in 2018

Background and Objectives: In Iran, cardiovascular disease is the leading cause of mortality. The economic burden of these diseases imposed on families makes the situation even worse. Health system policymakers need to be aware of the costs of these diseases to make wise decisions regarding the allocation of resources. The present study aimed to estimate the economic burden of cardiovascular di...

متن کامل

Cardiovascular toxicity of nicotine: Implications for electronic cigarette use.

The cardiovascular safety of nicotine is an important question in the current debate on the benefits vs. risks of electronic cigarettes and related public health policy. Nicotine exerts pharmacologic effects that could contribute to acute cardiovascular events and accelerated atherogenesis experienced by cigarette smokers. Studies of nicotine medications and smokeless tobacco indicate that the ...

متن کامل

Pay for Performance: A Reflection on How a Global Perspective Could Enhance Policy and Research

Pay-for-performance (P4P) is the provision of financial incentives to healthcare providers based on pre-specified performance targets. P4P has been used as a policy tool to improve healthcare provision globally. However, researchers tend to cluster into those working on high or low- and middle-income countries (LMICs), with still limited knowledge exchange, potentially ...

متن کامل

Health Policy in Cardiovascular Medicine

205 Cardiovascular disease is the leading cause of death in the United States and constitutes 17% of overall national health expenditures, with noninvasive testing contributing much of the cost growth in recent years. Cardiovascular medicine has long been at the forefront of evidence-based practice, with arguably the longest-standing and most comprehensive array of efforts to measure risk facto...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2015